EMVision completes pilot line, receives $1.25 million grant payment
Brain imaging company EMVision Medical Devices has completed its pilot commercial line and received a third and final milestone-related payment, worth $1.25 million, under the federal Modern Manufacturing Initiative. EMVision is developing bedside and portable machines for detecting stroke, with the former (known as emu) currently in clinical trials. In a statement to the ASX…











